Traws Pharma, Inc. - Common Stock (TRAW)
2.1500
-0.1700 (-7.33%)
NASDAQ · Last Trade: Apr 3rd, 12:10 PM EDT

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 3, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 13, 2025

Via Benzinga · January 16, 2025

Via Benzinga · January 13, 2025

Traws Pharma just reported results for the second quarter of 2024.
Via InvestorPlace · August 16, 2024

Via Benzinga · December 30, 2024

Via Benzinga · December 30, 2024

Via Benzinga · December 24, 2024

Via Benzinga · December 23, 2024

Via Benzinga · December 23, 2024

Traws Pharma (NASDAQ: TRAW) shares soar as company reports positive results for single-dose treatment of H5N1 bird flu. No adverse events reported.
Via Benzinga · December 23, 2024

Via Benzinga · November 18, 2024

Via Benzinga · September 30, 2024

Via Benzinga · July 4, 2024

Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter.
Via Benzinga · April 16, 2024

Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares.
Via Benzinga · April 4, 2024